The amino acid transporter SLC7A5 confers a poor prognosis in the highly proliferative breast cancer subtypes and is a key therapeutic target in luminal B tumours
Background: Breast cancer (BC) is a heterogeneous disease characterised by variant biology and patient outcome. The amino acid transporter, SLC7A5, plays a role in BC although its impact on patient outcome in different BC subtypes remains to be validated. This study aimed to determine whether the cl...
| Main Authors: | El Ansari, Rokaya, Craze, Madeleine L., Miligy, Islam, Diez-Rodriguez, Maria, Nolan, Christopher C., Ellis, Ian O., Rakha, Emad, Green, Andrew R. |
|---|---|
| Format: | Article |
| Published: |
BioMed Central
2018
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/49955/ |
Similar Items
The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes
by: El Ansari, Rokaya, et al.
Published: (2018)
by: El Ansari, Rokaya, et al.
Published: (2018)
FOXP1 expression correlates with better prognosis in invasive breast cancer including the ER-positive luminal subtype
by: Joseph, C., et al.
Published: (2017)
by: Joseph, C., et al.
Published: (2017)
MYC regulation of Glutamine-Proline regulatory axis is key in Luminal B breast cancer
by: Craze, Madeleine L., et al.
Published: (2017)
by: Craze, Madeleine L., et al.
Published: (2017)
Amino acid transporters in breast cancer: promising prognostic markers and emerging targets across molecular subtypes
by: El Ansari, Rokaya
Published: (2020)
by: El Ansari, Rokaya
Published: (2020)
Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes
by: Joseph, Chitra, et al.
Published: (2018)
by: Joseph, Chitra, et al.
Published: (2018)
Clinical and biological roles of Kelch-like family member 7 in breast cancer: a marker of poor prognosis
by: Kurozumi, Sasagu, et al.
Published: (2018)
by: Kurozumi, Sasagu, et al.
Published: (2018)
Phenotypic characterization of breast cancer: the role of CDC42
by: Chrysanthou, Eleni, et al.
Published: (2017)
by: Chrysanthou, Eleni, et al.
Published: (2017)
Rho-GTPase activating protein 18: a biomarker associated with good prognosis in invasive breast cancer
by: Aleskandarany, Mohammed A., et al.
Published: (2017)
by: Aleskandarany, Mohammed A., et al.
Published: (2017)
Altered glutamine metabolism in breast cancer: subtype dependencies and alternative adaptations
by: El Ansari, Rokaya, et al.
Published: (2017)
by: El Ansari, Rokaya, et al.
Published: (2017)
The significance of tumour microarchitectural features in breast cancer prognosis: a digital image analysis
by: Roxanis, I., et al.
Published: (2018)
by: Roxanis, I., et al.
Published: (2018)
Ki67 expression in invasive breast cancer: the use of tissue microarrays compared with whole tissue sections
by: Muftah, Abir A., et al.
Published: (2017)
by: Muftah, Abir A., et al.
Published: (2017)
An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation
by: Candido Dos Reis, Francisco J., et al.
Published: (2017)
by: Candido Dos Reis, Francisco J., et al.
Published: (2017)
Current issues with luminal subtype classification in terms of prediction of benefit from endocrine therapy in early breast cancer
by: Alfarsi, Lutfi, et al.
Published: (2018)
by: Alfarsi, Lutfi, et al.
Published: (2018)
Prognosis of sciatica and back-related leg pain in primary care: the ATLAS cohort
by: Konstantinou, Kika, et al.
Published: (2017)
by: Konstantinou, Kika, et al.
Published: (2017)
Loss of MED23 leads to poor prognosis in invasive breast
cancer
by: Aliyeva, T.A., et al.
Published: (2017)
by: Aliyeva, T.A., et al.
Published: (2017)
The presence of tumour-associated lymphocytes confers a good prognosis in pancreatic ductal adenocarcinoma: an immunohistochemical study of tissue microarrays
by: Tewari, Nilanjana, et al.
Published: (2013)
by: Tewari, Nilanjana, et al.
Published: (2013)
Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy
by: Blaxill, J., et al.
Published: (2021)
by: Blaxill, J., et al.
Published: (2021)
Cell division cycle 25C (CDC25C) expression confers poor prognosis in invasive breast cancer
by: Ojiegbe, S., et al.
Published: (2017)
by: Ojiegbe, S., et al.
Published: (2017)
Canine idiopathic chronic hepatitis
by: Bexfield, Nicholas
Published: (2017)
by: Bexfield, Nicholas
Published: (2017)
Expression of β-catenin, Ki67 and stroma percentage in colorectal cancer
by: Suanno, Cristina
Published: (2021)
by: Suanno, Cristina
Published: (2021)
Hepatic elastin content is predictive of adverse outcome in advanced fibrotic liver disease
by: Kendall, Timothy, et al.
Published: (2018)
by: Kendall, Timothy, et al.
Published: (2018)
Exploring the role of tumour microenvironment in the behaviour of breast ductal carcinoma in situ
by: Toss, Michael Salah Shawky
Published: (2020)
by: Toss, Michael Salah Shawky
Published: (2020)
Growth Hormone increases gonadotropin receptors in poor-prognosis patients
by: Regan, S., et al.
Published: (2012)
by: Regan, S., et al.
Published: (2012)
Ten-year outcomes in first episode psychotic major depression patients compared with schizophrenia and bipolar patients
by: Heslin, M., et al.
Published: (2016)
by: Heslin, M., et al.
Published: (2016)
Circulating microRNAs for the prediction of metastasis in breast cancer patients diagnosed with early stage disease
by: Inns, Joseph, et al.
Published: (2015)
by: Inns, Joseph, et al.
Published: (2015)
Preparing for the worst while hoping for the best: the relevance of hope in the heart failure illness trajectory
by: Davidson, Patricia, et al.
Published: (2007)
by: Davidson, Patricia, et al.
Published: (2007)
A validation study of the CirCom comorbidity score in an English cirrhosis population using the Clinical Practice Research Datalink
by: Crooks, Colin J., et al.
Published: (2018)
by: Crooks, Colin J., et al.
Published: (2018)
Prognostic factors for long-term outcomes in relapsing-remitting multiple sclerosis
by: Traboulsee, Anthony L., et al.
Published: (2016)
by: Traboulsee, Anthony L., et al.
Published: (2016)
IL-6 and IL-10 are associated with good prognosis in early stage invasive breast cancer patients
by: Ahmad, Narmeen, et al.
Published: (2018)
by: Ahmad, Narmeen, et al.
Published: (2018)
SLC22A1, SLC22A2, SLC22A3 and 11ßHSD1 gene polymorphisms among Malaysian Indians with type 2 diabetes mellitus
by: Abood, Al Ashoor Sabah Ghasan
Published: (2019)
by: Abood, Al Ashoor Sabah Ghasan
Published: (2019)
Live birth rates are satisfactory following multiple IVF treatment cycles
in poor prognosis patients
by: Mustafa, Kamarul Bahyah, et al.
Published: (2017)
by: Mustafa, Kamarul Bahyah, et al.
Published: (2017)
Live birth rates are satisfactory following multiple IVF treatment cycles in poor prognosis patients
by: Mustafa, K., et al.
Published: (2017)
by: Mustafa, K., et al.
Published: (2017)
Single-centre retrospective analysis of growth hormone supplementation in IVF patients classified as poor-prognosis
by: Keane, Kevin, et al.
Published: (2017)
by: Keane, Kevin, et al.
Published: (2017)
Subtractive hybridization identifies stem cell-associated genes in an acute myeloid leukemia with poor prognosis
by: Ngiow, Shin Foong, et al.
Published: (2016)
by: Ngiow, Shin Foong, et al.
Published: (2016)
Growth hormone supplementation improves implantation and pregnancy productivity rates for poor-prognosis patients undertaking IVF
by: Yovich, John, et al.
Published: (2010)
by: Yovich, John, et al.
Published: (2010)
Association of SLC6A4 gene polymorphisms with Schizophrenia
by: Aladzemi, Farah Wahida, et al.
Published: (2015)
by: Aladzemi, Farah Wahida, et al.
Published: (2015)
B-blockers, calcium antagonists, and mortality in stable coronary artery disease: An international cohort study
by: Sorbets, E., et al.
Published: (2019)
by: Sorbets, E., et al.
Published: (2019)
Trends from 1996 to 2007 in incidence and mortality outcomes of heart failure after acute myocardial infarction: A population-based study of 20 812 patients with first acute myocardial infarction in Western Australia
by: Hung, J., et al.
Published: (2013)
by: Hung, J., et al.
Published: (2013)
Pericytes promote malignant ovarian cancer progression in mice and predict poor prognosis in serous ovarian cancer patients
by: Sinha, D., et al.
Published: (2016)
by: Sinha, D., et al.
Published: (2016)
Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification
by: Aleskandarany, Mohammed A., et al.
Published: (2015)
by: Aleskandarany, Mohammed A., et al.
Published: (2015)
Similar Items
-
The multifunctional solute carrier 3A2 (SLC3A2) confers a poor prognosis in the highly proliferative breast cancer subtypes
by: El Ansari, Rokaya, et al.
Published: (2018) -
FOXP1 expression correlates with better prognosis in invasive breast cancer including the ER-positive luminal subtype
by: Joseph, C., et al.
Published: (2017) -
MYC regulation of Glutamine-Proline regulatory axis is key in Luminal B breast cancer
by: Craze, Madeleine L., et al.
Published: (2017) -
Amino acid transporters in breast cancer: promising prognostic markers and emerging targets across molecular subtypes
by: El Ansari, Rokaya
Published: (2020) -
Mediator complex (MED) 7: a biomarker associated with good prognosis in invasive breast cancer, especially ER+ luminal subtypes
by: Joseph, Chitra, et al.
Published: (2018)